Physician profile
Allison T Gray
NPI 1396109534
$1,249.47
in general payments reported to CMS, 2019-2025
21 companies · $266 in 2025
The $266 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $71.41 · 2022: $325 · 2023: $364 · 2024: $223 · 2025: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $852.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $241.57 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $101.03 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $89.85 | 2023-2025 | Myfembree, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $79.51 | 2021-2025 | |
| Biogen, INC. | $75.32 | 2024-2025 | Zurzuvae |
| Myriad Women'S Health, INC. | $70.86 | 2023 | Myrisk |
| Agile Therapeutics, INC. | $70.09 | 2021-2023 | Twirla |
| Astellas Pharma US INC | $69.89 | 2024-2025 | Veozah |
| Organon LLC | $66.16 | 2024-2025 | Nexplanon |
| Exeltis, USA INC. | $57.26 | 2022-2025 | Slynd |
| Hologic Sales and Service, LLC | $54.32 | 2023-2024 | Acessa Provu System, Thinprep 2000 Processor, Aptima |
| Novo Nordisk INC | $44.57 | 2023-2024 | Wegovy |
| Myovant Sciences INC. | $37.66 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $33.46 | 2022-2023 | Vivjoa |
| Boston Scientific Corporation | $29.02 | 2023 | Upsylon |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $26.60 | 2021 | |
| Shield Therapeutics INC | $25.60 | 2024 | |
| Scynexis, INC. | $23.98 | 2022 | |
| Avion Pharmaceuticals | $20.87 | 2023 | Balcoltra |
| Coopersurgical, INC. | $15.95 | 2024 | Paragard T 380a |
| Amgen INC. | $15.90 | 2025 | Evenity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.